clvt stock: Clarivate Plc Overview

CLVT (Clarivate Plc) — Stock overview

clvt stock is the NYSE ticker symbol for Clarivate Plc, a publicly traded company that provides information, analytics and workflow solutions to customers across academia, life sciences, intellectual property, and brand protection. This article gives a structured, investor-focused overview of Clarivate’s business, history, governance, financial profile, stock characteristics, risks, and comparables. Readers will learn where Clarivate generates recurring revenue, what flagship products it operates, and which factors commonly shape market expectations for CLVT. For traders and holders of CLVT, we note that Bitget supports trading of U.S.-listed equities and that Bitget Wallet is an option for secure custody and related services.

Company profile

Clarivate Plc operates as a provider of data, analytics and workflow solutions that help organizations discover, protect and commercialize ideas and intellectual property, support academic and scientific research, and accelerate drug development and clinical decision-making. The company serves a broad base of customers including universities and research institutions, pharmaceutical and biotech companies, patent offices and IP law firms, publishers, and brand owners.

• Headquarters: Clarivate is incorporated and operates with global offices across North America, Europe, and the Asia-Pacific region.
• Founding / formation: Clarivate traces its corporate roots to legacy information and analytics businesses and was formally created through the acquisition and consolidation of several research and IP assets.
• Scale: Clarivate operates globally across dozens of countries and employs thousands of people in product, sales, research and data operations.

(As of 2026-01-29, per major financial quote pages and company investor communications, Clarivate maintains a multi-regional workforce and global product footprint; see References.)

Business segments

Clarivate’s product portfolio is commonly described across several operating segments or go-to-market verticals. The exact segment labels can vary over time in company filings, but they broadly include:

• Academia & Government: Platforms and datasets that support research discovery, citation analytics, institutional benchmarking, and government research performance measurement. Customers include universities, libraries, research funders and government agencies.
• Intellectual Property (IP) Solutions: Databases and workflow tools that support patent search, patent analytics, patent prosecution and IP portfolio management. This area typically includes patent data indexing and branded services for patent analytics professionals.
• Life Sciences & Healthcare: Drug discovery and clinical development intelligence, safety and regulatory data, and workflow tools to help pharmaceutical and biotech organizations speed research and development and meet regulatory obligations.
• Brand Protection & Market Intelligence: Services that help corporations manage trademarks, brand enforcement, domain protection and digital risk monitoring.

Each segment is built around large, specialized datasets and workflow software that are typically sold on a subscription or recurring contract basis, contributing to recurring revenue characteristics.

Products and services

Clarivate’s flagship products and platforms are widely recognized in research, IP and life-science communities. Notable products commonly associated with the company include:

• Web of Science: A citation and research discovery platform used by researchers and institutions for literature search, citation analytics and research evaluation.
• Cortellis: A suite of drug development, regulatory and clinical intelligence tools used across R&D and regulatory teams in life sciences.
• Derwent: Patent indexing and patent analytics services that support patent search and intellectual property workflows.
• ProQuest / Ebook Central: Academic content and library services (following the company’s acquisition of ProQuest, which expanded its academic and library offerings).
• MarkMonitor and CompuMark: Brand protection and trademark intelligence services used by corporate clients.
• EndNote and ScholarOne: Authoring, reference management and journal submission tools that integrate with academic workflows.

Customers range from individual researchers and academic libraries to global corporations, IP law firms, governmental bodies, and pharmaceutical companies. The products are often combined into enterprise contracts and supplemented by professional services.

Corporate history

Clarivate’s corporate history is characterized by the consolidation of legacy information businesses and a series of strategic acquisitions that expanded its product scope:

• Predecessor businesses: Many of Clarivate’s core assets trace back to long-standing information businesses in scientific publishing, patent indexing and bibliographic data.
• Formation: Clarivate was formed when a package of intellectual property, science and analytics assets were acquired and consolidated under the Clarivate brand; the company subsequently developed a strategy of expanding via acquisitions and product integration.
• Strategic acquisitions: Over multiple years, Clarivate completed acquisitions that broadened its content and workflow offerings—most notably in areas of academic content, patent intelligence, and brand protection. These moves strengthened Clarivate’s position across research, life sciences and IP markets.
• Public listing and capital markets activity: Clarivate’s securities trade under the ticker CLVT on the New York Stock Exchange. The company’s public filings and investor presentations document the strategic rationale for acquisitions and capital allocation decisions.

(For a chronological list of major corporate events and exact transaction dates, consult the company’s investor relations releases and regulatory filings listed in References and External links.)

Corporate governance and management

Clarivate is governed by a board of directors and executive management team responsible for strategic direction, financial oversight and operational execution. Governance highlights typically disclosed in filings include board composition (independent directors vs. executive directors), executive compensation policies, and committee structures for audit, compensation and governance.

• Executive leadership: The company’s CEO and senior executives lead product strategy, M&A integration, and global operations. For up-to-date names and biographies of the CEO and other executives, consult the company’s investor relations disclosures.
• Board and committees: Clarivate’s board includes experienced executives and directors with backgrounds in information services, technology and corporate finance. The board oversees risk management, strategic planning and shareholder matters.
• Headquarters and corporate structure: Clarivate operates legal entities across multiple jurisdictions; its primary incorporation and reporting obligations are disclosed in regulatory filings.

Financial performance

Clarivate’s financial profile is shaped by recurring subscription revenue, professional services, and revenue from content licensing. Key financial themes investors and analysts watch include revenue growth, subscription retention, gross margins on data and software products, operating leverage, free cash flow generation, and progress in debt reduction.

• Revenue and profitability: Historically, Clarivate has reported growth driven by product expansion and acquisitions, offset at times by integration costs and restructuring. Profitability trends can differ quarter-to-quarter depending on investment in product development and M&A-related charges.
• Margins and cash flow: Subscription and data products generally yield high gross margins; operating margin and free cash flow are affected by sales and marketing investments and amortization of acquired intangibles.
• Recent quarter highlights: As of the latest public reporting window, Clarivate’s earnings releases and investor presentations provide detailed revenue segmentation, operating income and free cash flow figures—readers should consult those filings for precise, up-to-date metrics.

Note: All financial figures should be verified against the company’s latest annual report, quarterly filings and investor presentations listed in References.

Stock information

Ticker and listing

• Ticker symbol: CLVT
• Exchange: New York Stock Exchange (NYSE)
• Identifiers: Standard identifiers such as ISIN and CUSIP are disclosed in regulatory filings and on the company’s investor relations pages.

Market data and trading characteristics

CLVT is an NYSE-listed equity with trading activity that reflects coverage by institutional investors and retail interest. Typical data points of interest to traders include market capitalization, public float, average daily trading volume, and average bid-ask spreads on U.S. hours and extended trading sessions.

As of 2026-01-29, per major market quote pages and the company’s IR disclosures, real-time market capitalization, daily trading volume and other live metrics for clvt stock are available on financial data portals and should be checked directly for trading decisions.

Historical price performance

CLVT’s historical price performance is influenced by quarterly results, acquisition news, changes in sector sentiment for information services, and macro market factors. Investors commonly examine multi-period returns (1 month / 6 months / 1 year / 5 year) and overlay event marks such as earnings releases and major corporate announcements to interpret price moves.

Dividends, buybacks and capital return policy

Clarivate’s capital return approach has historically prioritized strategic investment and debt management. Dividend policy and share repurchase programs (if any) are disclosed in company filings and press releases. Investors should consult the company’s most recent investor relations communications for any active buyback authorizations or dividend declarations.

Analyst coverage, price targets and ratings

CLVT receives coverage from equity research analysts and independent platforms that publish ratings and price targets. Analyst consensus and target ranges are helpful context but vary by firm and model. Platforms such as Morningstar, TipRanks and leading market news outlets commonly summarize analyst sentiment and target revisions.

Ownership and shareholders

Institutional investors and mutual funds commonly hold significant stakes in publicly traded information services companies; Clarivate is no exception. Ownership disclosures in regulatory filings (e.g., institutional holdings summaries and 13F filings where applicable) identify major institutional holders, insider ownership and changes in concentration over time. Activist investor involvement or board-level engagement would be disclosed in filings if present.

For current lists of top institutional holders and insider stakes in clvt stock, consult the company’s investor relations pages and major market data providers.

Risks and controversies

Investors should consider several types of risk relevant to Clarivate and similar information services companies:

• Competitive risk: Competition from large-scale publishers, data platforms and niche analytics providers can pressure pricing and product differentiation.
• Integration and acquisition risk: Clarivate’s growth strategy includes acquisitions; successful integration is required to realize anticipated synergies and to avoid churn or cost overruns.
• Data quality and intellectual property risk: As an information provider, Clarivate depends on the accuracy and completeness of proprietary datasets. Data errors or disputes over content licensing can have reputational and legal implications.
• Regulatory and compliance risk: Operating across many jurisdictions exposes the company to varying regulations on data use, privacy and competition law.
• Macroeconomic and market risk: Changes in institutional spending on research subscriptions or corporate budgets for IP services may affect demand.
• Litigation and legal claims: Any material securities litigation, class actions or IP disputes are disclosed in regulatory filings and may be reported by major news outlets.

(As of 2026-01-29, market watchers should review the latest regulatory filings and news releases to identify any new legal matters or material contingencies.)

Recent developments and corporate strategy

Clarivate’s stated strategic priorities typically emphasize:

• Expanding high-value subscription and workflow products that deliver recurring revenue and high retention.
• Integrating acquired businesses to cross-sell products across customer bases (for example, offering IP services to life-sciences customers and vice versa).
• Investing in product development and data quality to maintain market leadership in research analytics, patent intelligence and drug development intelligence.
• Managing leverage and improving free cash flow through operational efficiencies.

Recent earnings reports and investor presentations detail progress on these themes, including revenue mix shifts, margin expansion targets, and guidance updates. For precise recent developments and management commentary, consult the latest investor releases listed in References.

Investment considerations

This section is informational and not investment advice. It summarizes factors that investors and analysts weigh when evaluating clvt stock:

Bullish considerations

• Market-leading datasets and brands: Clarivate owns widely used research and IP brands that can command premium pricing and high retention.
• Recurring revenue model: Subscription and enterprise contracts provide predictable revenue streams.
• Cross-sell and product synergies: Acquisitions expand addressable markets and create opportunities to bundle offerings across customer segments.

Bearish considerations

• Debt and leverage: Growth through acquisition can increase leverage; servicing debt can constrain discretionary spending.
• Integration risk and execution: Failure to integrate acquisitions or to retain customers post-merger could harm revenue growth.
• Competitive pressures: Established and emerging competitors in research analytics, IP services and life-science intelligence can pressure pricing and market share.

Investors should weigh these factors alongside up-to-date financial metrics, management guidance and industry trends.

Valuation metrics and comparables

Common valuation metrics for clvt stock include price-to-sales (P/S), enterprise-value-to-EBITDA (EV/EBITDA), and price-to-earnings (P/E) when the company reports positive, stable earnings. Peer comparables often used when valuing Clarivate include other information and analytics companies such as RELX, Thomson Reuters and Wolters Kluwer, which operate subscription-based models and global data platforms.

Analysts and independent valuation platforms publish fair-value estimates and target multiples based on forecasted revenue growth and margin expansion. For model inputs and consensus estimates, consult recognized research providers and the company’s guidance in investor presentations.

Notable events timeline (chronology)

• Formation and consolidation of legacy information assets into the Clarivate group.
• Sequential acquisitions that expanded the company’s footprint in academic content, patent intelligence and brand protection.
• Public listing and ongoing investor communications detailing strategy and performance.
• Operational and financial milestones reported in quarterly and annual filings (earnings beats/misses, restructuring announcements, buyback authorizations, etc.).

(For specific dates and event descriptions, see the References and company filings.)

See also

• New York Stock Exchange (NYSE)
• Equity valuation metrics (P/S, EV/EBITDA, P/E)
• Peer companies in information and analytics

References

• Clarivate Plc — company investor relations and filings (investor relations releases and annual reports). (As of 2026-01-29, consult company filings for current data.)
• CLVT quote pages and market data on major finance portals and stock quote services (e.g., Yahoo Finance, Morningstar, TradingView and major business news sites). (As of 2026-01-29, these services display live market data for clvt stock.)
• Selected analyst platforms and summaries (TipRanks, Morningstar, The Motley Fool) for analyst coverage and fair-value commentary.
• New York Stock Exchange — CLVT listing details and market notices.

External links

• Clarivate investor relations (official company IR page)
• SEC and equivalent regulatory filings for Clarivate (filings and periodic reports)
• Market quote pages for CLVT on major finance portals (for live price, market cap and volume)

Practical next steps: If you are interested in trading or tracking CLVT, use a regulated brokerage or trading platform such as Bitget to place orders in U.S.-listed equities. For custody and safe handling of credentials and related assets, consider Bitget Wallet. Always verify the latest market data and company filings before making trading decisions.

Reporting note: As of 2026-01-29, per mainstream market quote pages and company investor communications, live price and market metrics for clvt stock are available on the platforms cited in References. For precise numbers (market capitalization, average daily volume, recent quarter revenue and net income), consult the company’s most recent 10-Q / annual report and major financial quote pages.